← Leaderboards
Stuart G Campbell
Yale University
$6,631,485
Attributed
$11,766,024
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,766,024 · 5
By mechanism
R01$11,308,149 · 4
R21$457,875 · 1
Top collaborators
- Kenneth S Campbell4 shared
- John Travis Hinson4 shared
- Jian-Ping Jin4 shared
- Julian Stelzer4 shared
- Fadi Gabriel Akar3 shared
- William J Lehman3 shared
- Jeffrey R Moore3 shared
Most similar at Yale University
Same institution · by research overlap
- Christopher Gerard Bunick$2,735,901
- Marina R. Picciotto$36,006,961
- Karen Muller Smith$653,630
- Matthew W Ellis$245,884
- Ryland Mortlock$34,522
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacMutationProteinsVariantMolecularCellsSarcomeresGenesGeneticMechanicsPathogenicityMyocardiumLinkExperimental StudyHeartBehaviorCardiac Tissue EngineeringPhenotypeResponseHeart FailureActinsComputing MethodologiesCardiomyopathiesHeart Diseases
Grant awards (22)
Computational Pipeline for Identification of Disease-Causing Variants in Genes of the Cardiac Sarcomere$679,561
R01 · FY2025 · HL · contact PI
Desmoplakinopathies: Integrated Pathophysiology and Therapeutics$673,551
R01 · FY2025 · HL · contact PI
Establishing and reversing the functional consequences of Titin truncation mutations$529,054
R01 · FY2025 · HL
Computational Pipeline for Identification of Disease-Causing Variants in Genes of the Cardiac Sarcomere$665,971
R01 · FY2024 · HL · contact PI
Desmoplakinopathies: Integrated Pathophysiology and Therapeutics$660,080
R01 · FY2024 · HL · contact PI
Establishing and reversing the functional consequences of Titin truncation mutations$518,473
R01 · FY2024 · HL
Computational Pipeline for Identification of Disease-Causing Variants in Genes of the Cardiac Sarcomere$713,311
R01 · FY2023 · HL · contact PI
Desmoplakinopathies: Integrated Pathophysiology and Therapeutics$673,551
R01 · FY2023 · HL · contact PI
Establishing and reversing the functional consequences of Titin truncation mutations$529,054
R01 · FY2023 · HL
Establishing and reversing the functional consequences of Titin truncation mutations$566,102
R01 · FY2022 · HL
Computer modeling of myosin binding protein C and its effects on cardiac contraction$551,684
R01 · FY2022 · HL
Computer modeling of myosin binding protein C and its effects on cardiac contraction$551,684
R01 · FY2021 · HL
Revealing Pathomechanisms of Mutant TPM1 Through a Hybrid Computational-Experimental Approach$548,314
R01 · FY2021 · HL · contact PI
Revealing Pathomechanisms of Mutant TPM1 Through a Hybrid Computational-Experimental Approach$78,376
R01 · FY2021 · HL · contact PI
Computer modeling of myosin binding protein C and its effects on cardiac contraction$551,216
R01 · FY2020 · HL
Revealing Pathomechanisms of Mutant TPM1 Through a Hybrid Computational-Experimental Approach$548,314
R01 · FY2020 · HL · contact PI
Computer modeling of myosin binding protein C and its effects on cardiac contraction$594,809
R01 · FY2019 · HL
Revealing Pathomechanisms of Mutant TPM1 Through a Hybrid Computational-Experimental Approach$548,314
R01 · FY2019 · HL · contact PI
Revealing Pathomechanisms of Mutant TPM1 Through a Hybrid Computational-Experimental Approach$548,314
R01 · FY2018 · HL · contact PI
Revealing Pathomechanisms of Mutant TPM1 Through a Hybrid Computational-Experimental Approach$578,416
R01 · FY2017 · HL · contact PI
Engineered Tissue for Biomechanical Phenotyping of Cardiomyopathy Patients$208,125
R21 · FY2016 · HL · contact PI
Engineered Tissue for Biomechanical Phenotyping of Cardiomyopathy Patients$249,750
R21 · FY2015 · HL · contact PI